Oral mucosal pigmentation induced by vandetanib therapy: First clinicopathological characterization
Gespeichert in:
| Veröffentlicht in: | Oral oncology 2020-10, Vol.109, p.104747-104747, Article 104747 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 104747 |
|---|---|
| container_issue | |
| container_start_page | 104747 |
| container_title | Oral oncology |
| container_volume | 109 |
| creator | Vigarios, E. Maret, D. Herbaut-Barres, B. Zerdoud, S. Sibaud, V. |
| description | |
| doi_str_mv | 10.1016/j.oraloncology.2020.104747 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04853675v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1368837520301834</els_id><sourcerecordid>2404378845</sourcerecordid><originalsourceid>FETCH-LOGICAL-c272t-821b3bedde1e0f44f22f1a7ef06452e329d4687147ffc30e82e04489c22044933</originalsourceid><addsrcrecordid>eNqNkU9P3DAQxa2qFVDar1BFPbWHbP0vscMN0QKVVuICZ8txJqxXiZ3azkrLp6_TAOLY0xuNf_PGmofQV4I3BJP6x37jgx68M37wj8cNxXR54IKLd-iMSNGUuGrY-1yzWpaSieoUfYxxjzGuSIVP0CmjnEhZ0zNk7rJVMc7Gx6yTfRzBJZ2sd4V13WygK9pjcdCug6SdbYu0g6Cn40VxbUNMhRmss8ZPOu2W31iTXcxOB20SBPv0z-kT-tDrIcLnZz1HD9e_7q9uy-3dze-ry21pqKCplJS0rIWuAwK457yntCdaQI9rXlFgtOl4LQXhou8NwyApYM5lYyjN2jB2jr6vvjs9qCnYUYej8tqq28utWnqYy4rVojqQzH5b2Sn4PzPEpEYbDQyDduDnqCjHnAkpeZXRixU1wccYoH_1Jlgtgai9ehuIWgJRayB5-MvznrkdoXsdfUkgAz9XAPJlDhaCisaCy4e3AUxSnbf_s-cvdAekRw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2404378845</pqid></control><display><type>article</type><title>Oral mucosal pigmentation induced by vandetanib therapy: First clinicopathological characterization</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Vigarios, E. ; Maret, D. ; Herbaut-Barres, B. ; Zerdoud, S. ; Sibaud, V.</creator><creatorcontrib>Vigarios, E. ; Maret, D. ; Herbaut-Barres, B. ; Zerdoud, S. ; Sibaud, V.</creatorcontrib><identifier>ISSN: 1368-8375</identifier><identifier>EISSN: 1879-0593</identifier><identifier>DOI: 10.1016/j.oraloncology.2020.104747</identifier><identifier>PMID: 32418862</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Aged ; Biopsy ; Ecology, environment ; Hard palate ; Health ; Humanities and Social Sciences ; Humans ; Hyperpigmentation ; Immunohistochemistry ; Life Sciences ; Male ; Mouth Mucosa - pathology ; Oral mucosa ; Pigmentation - drug effects ; Piperidines - adverse effects ; Piperidines - therapeutic use ; Protein Kinase Inhibitors - adverse effects ; Protein Kinase Inhibitors - therapeutic use ; Quinazolines - adverse effects ; Quinazolines - therapeutic use ; Targeted therapy ; Vandetanib</subject><ispartof>Oral oncology, 2020-10, Vol.109, p.104747-104747, Article 104747</ispartof><rights>2020 Elsevier Ltd</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c272t-821b3bedde1e0f44f22f1a7ef06452e329d4687147ffc30e82e04489c22044933</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.oraloncology.2020.104747$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,778,782,883,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32418862$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04853675$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Vigarios, E.</creatorcontrib><creatorcontrib>Maret, D.</creatorcontrib><creatorcontrib>Herbaut-Barres, B.</creatorcontrib><creatorcontrib>Zerdoud, S.</creatorcontrib><creatorcontrib>Sibaud, V.</creatorcontrib><title>Oral mucosal pigmentation induced by vandetanib therapy: First clinicopathological characterization</title><title>Oral oncology</title><addtitle>Oral Oncol</addtitle><subject>Aged</subject><subject>Biopsy</subject><subject>Ecology, environment</subject><subject>Hard palate</subject><subject>Health</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>Hyperpigmentation</subject><subject>Immunohistochemistry</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Mouth Mucosa - pathology</subject><subject>Oral mucosa</subject><subject>Pigmentation - drug effects</subject><subject>Piperidines - adverse effects</subject><subject>Piperidines - therapeutic use</subject><subject>Protein Kinase Inhibitors - adverse effects</subject><subject>Protein Kinase Inhibitors - therapeutic use</subject><subject>Quinazolines - adverse effects</subject><subject>Quinazolines - therapeutic use</subject><subject>Targeted therapy</subject><subject>Vandetanib</subject><issn>1368-8375</issn><issn>1879-0593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU9P3DAQxa2qFVDar1BFPbWHbP0vscMN0QKVVuICZ8txJqxXiZ3azkrLp6_TAOLY0xuNf_PGmofQV4I3BJP6x37jgx68M37wj8cNxXR54IKLd-iMSNGUuGrY-1yzWpaSieoUfYxxjzGuSIVP0CmjnEhZ0zNk7rJVMc7Gx6yTfRzBJZ2sd4V13WygK9pjcdCug6SdbYu0g6Cn40VxbUNMhRmss8ZPOu2W31iTXcxOB20SBPv0z-kT-tDrIcLnZz1HD9e_7q9uy-3dze-ry21pqKCplJS0rIWuAwK457yntCdaQI9rXlFgtOl4LQXhou8NwyApYM5lYyjN2jB2jr6vvjs9qCnYUYej8tqq28utWnqYy4rVojqQzH5b2Sn4PzPEpEYbDQyDduDnqCjHnAkpeZXRixU1wccYoH_1Jlgtgai9ehuIWgJRayB5-MvznrkdoXsdfUkgAz9XAPJlDhaCisaCy4e3AUxSnbf_s-cvdAekRw</recordid><startdate>202010</startdate><enddate>202010</enddate><creator>Vigarios, E.</creator><creator>Maret, D.</creator><creator>Herbaut-Barres, B.</creator><creator>Zerdoud, S.</creator><creator>Sibaud, V.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>BXJBU</scope></search><sort><creationdate>202010</creationdate><title>Oral mucosal pigmentation induced by vandetanib therapy: First clinicopathological characterization</title><author>Vigarios, E. ; Maret, D. ; Herbaut-Barres, B. ; Zerdoud, S. ; Sibaud, V.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c272t-821b3bedde1e0f44f22f1a7ef06452e329d4687147ffc30e82e04489c22044933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Aged</topic><topic>Biopsy</topic><topic>Ecology, environment</topic><topic>Hard palate</topic><topic>Health</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>Hyperpigmentation</topic><topic>Immunohistochemistry</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Mouth Mucosa - pathology</topic><topic>Oral mucosa</topic><topic>Pigmentation - drug effects</topic><topic>Piperidines - adverse effects</topic><topic>Piperidines - therapeutic use</topic><topic>Protein Kinase Inhibitors - adverse effects</topic><topic>Protein Kinase Inhibitors - therapeutic use</topic><topic>Quinazolines - adverse effects</topic><topic>Quinazolines - therapeutic use</topic><topic>Targeted therapy</topic><topic>Vandetanib</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vigarios, E.</creatorcontrib><creatorcontrib>Maret, D.</creatorcontrib><creatorcontrib>Herbaut-Barres, B.</creatorcontrib><creatorcontrib>Zerdoud, S.</creatorcontrib><creatorcontrib>Sibaud, V.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>HAL-SHS: Archive ouverte en Sciences de l'Homme et de la Société</collection><jtitle>Oral oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vigarios, E.</au><au>Maret, D.</au><au>Herbaut-Barres, B.</au><au>Zerdoud, S.</au><au>Sibaud, V.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral mucosal pigmentation induced by vandetanib therapy: First clinicopathological characterization</atitle><jtitle>Oral oncology</jtitle><addtitle>Oral Oncol</addtitle><date>2020-10</date><risdate>2020</risdate><volume>109</volume><spage>104747</spage><epage>104747</epage><pages>104747-104747</pages><artnum>104747</artnum><issn>1368-8375</issn><eissn>1879-0593</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>32418862</pmid><doi>10.1016/j.oraloncology.2020.104747</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1368-8375 |
| ispartof | Oral oncology, 2020-10, Vol.109, p.104747-104747, Article 104747 |
| issn | 1368-8375 1879-0593 |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_04853675v1 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Aged Biopsy Ecology, environment Hard palate Health Humanities and Social Sciences Humans Hyperpigmentation Immunohistochemistry Life Sciences Male Mouth Mucosa - pathology Oral mucosa Pigmentation - drug effects Piperidines - adverse effects Piperidines - therapeutic use Protein Kinase Inhibitors - adverse effects Protein Kinase Inhibitors - therapeutic use Quinazolines - adverse effects Quinazolines - therapeutic use Targeted therapy Vandetanib |
| title | Oral mucosal pigmentation induced by vandetanib therapy: First clinicopathological characterization |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T07%3A55%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20mucosal%20pigmentation%20induced%20by%20vandetanib%20therapy:%20First%20clinicopathological%20characterization&rft.jtitle=Oral%20oncology&rft.au=Vigarios,%20E.&rft.date=2020-10&rft.volume=109&rft.spage=104747&rft.epage=104747&rft.pages=104747-104747&rft.artnum=104747&rft.issn=1368-8375&rft.eissn=1879-0593&rft_id=info:doi/10.1016/j.oraloncology.2020.104747&rft_dat=%3Cproquest_hal_p%3E2404378845%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2404378845&rft_id=info:pmid/32418862&rft_els_id=S1368837520301834&rfr_iscdi=true |